GENUS INC
DEF 14A, 1995-04-27
SPECIAL INDUSTRY MACHINERY, NEC
Previous: KEY PRODUCTION CO INC, DEF 14A, 1995-04-27
Next: KUSHNER LOCKE CO, 10-K/A, 1995-04-27



<PAGE>
                            SCHEDULE 14A INFORMATION

                  Proxy Statement Pursuant to Section 14(a) of
                      the Securities Exchange Act of 1934

    Filed by the Registrant /X/
    Filed by a Party other than the Registrant / /

    Check the appropriate box:
    / /  Preliminary Proxy Statement
    / /  Confidential, for Use of the Commission Only (as permitted by Rule
         14a-6(e)(2))
    /X/  Definitive Proxy Statement
    / /  Definitive Additional Materials
    / /  Soliciting  Material  Pursuant  to  Section  240.14a-11(c)  or  Section
         240.14a-12

                                              GENUS, INC.
- - --------------------------------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)

                                              GENUS, INC.
- - --------------------------------------------------------------------------------
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

/X/  $125 per  Exchange Act  Rules 0-11(c)(1)(ii),  14a-6(i)(1), 14a-6(i)(2)  or
     Item 22(a)(2) of Schedule 14A.
/ /  $500  per  each party  to  the controversy  pursuant  to Exchange  Act Rule
     14a-6(i)(3).
/ /  Fee  computed  on   table  below   per  Exchange   Act  Rules   14a-6(i)(4)
     and 0-11.
     1) Title of each class of securities to which transaction applies:
        ------------------------------------------------------------------------
     2) Aggregate number of securities to which transaction applies:
        ------------------------------------------------------------------------
     3) Per unit price or other underlying value of transaction computed
        pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
        filing fee is calculated and state how it was determined):
        ------------------------------------------------------------------------
     4) Proposed maximum aggregate value of transaction:
        ------------------------------------------------------------------------
     5) Total fee paid:
        ------------------------------------------------------------------------
/ /  Fee paid previously with preliminary materials.
/ /  Check box if any part of the fee is offset as provided by Exchange Act Rule
     0-11(a)(2)  and identify the  filing for which the  offsetting fee was paid
     previously. Identify the previous filing by registration statement  number,
     or the Form or Schedule and the date of its filing.
     1) Amount Previously Paid:
        ------------------------------------------------------------------------
     2) Form, Schedule or Registration Statement No.:
        ------------------------------------------------------------------------
     3) Filing Party:
        ------------------------------------------------------------------------
     4) Date Filed:
        ------------------------------------------------------------------------
<PAGE>
                                  GENUS, INC.
                               ------------------

                    NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
                           TO BE HELD ON MAY 23, 1995
                             ---------------------

TO THE SHAREHOLDERS:

    NOTICE  IS HEREBY  GIVEN that the  Annual Meeting of  Shareholders of Genus,
Inc. (the "Company") will be held on  Tuesday, May 23, 1995 at 3:00 p.m.,  local
time,  at  the  Santa  Clara  Marriott Hotel  located  at  2700  Mission College
Boulevard, Santa Clara, California 95052, for the following purposes:

    1.   To elect  directors  to serve  for the  ensuing  year and  until  their
       successors are elected.

    2.    To  approve an  amendment  to  the 1991  Incentive  Stock  Option Plan
       increasing the  number  of shares  reserved  for issuance  thereunder  by
       500,000 additional shares.

    3.    To approve  an  amendment to  the  1989 Employee  Stock  Purchase Plan
       increasing the  number  of shares  reserved  for issuance  thereunder  by
       250,000 additional shares.

    4.    To ratify  the appointment  of  Coopers &  Lybrand LLP  as independent
       auditors of the Company for the fiscal year ending December 31, 1995.

    5.  To transact such other business as may properly come before the  meeting
       or any adjournment thereof.

    The  foregoing  items of  business  are more  fully  described in  the Proxy
Statement accompanying this Notice.

    Only shareholders of record at the close  of business on March 31, 1995  are
entitled to vote at the meeting.

    All  shareholders are  cordially invited  to attend  the meeting  in person.
However, to ensure your  representation at the meeting,  you are urged to  mark,
sign,  date and return  the enclosed proxy  card as promptly  as possible in the
self-addressed stamped  envelope  enclosed  for that  purpose.  Any  shareholder
attending the meeting may vote in person even if he or she returned a proxy.

                                          FOR THE BOARD OF DIRECTORS

                                          William W. R. Elder
                                          CHAIRMAN OF THE BOARD
                                          AND CHIEF EXECUTIVE OFFICER

Sunnyvale, California
April 26, 1995
<PAGE>
                                  GENUS, INC.
                               ------------------

               PROXY STATEMENT FOR ANNUAL MEETING OF SHAREHOLDERS
                             ---------------------

    The  enclosed  Proxy is  solicited on  behalf of  Genus, Inc.,  a California
corporation (the "Company") for use at the Annual Meeting of Shareholders to  be
held  Tuesday, May  23, 1995, at  3:00 p.m.,  local time, or  at any adjournment
thereof, for the  purposes set forth  herein and in  the accompanying Notice  of
Annual  Meeting of Shareholders.  The Annual Meeting  will be held  at the Santa
Clara Marriott Hotel,  2700 Mission College  Boulevard, Santa Clara,  California
95052.  The  principal executive  offices  of the  Company  are located  at 1139
Karlstad Drive, Sunnyvale, California 94089.  The Company's telephone number  at
that location is (408) 747-7120.

    These proxy solicitation materials were mailed on or about April 26, 1995 to
all shareholders entitled to vote at the meeting.

                 INFORMATION CONCERNING SOLICITATION AND VOTING

VOTING

    Each share of Common Stock outstanding on the record date is entitled to one
vote.  In addition, every shareholder,  or his or her  proxy, who is entitled to
vote upon the election  of directors may cumulate  such shareholder's votes  and
give  one candidate  a number of  votes equal to  the number of  directors to be
elected multiplied  by  the  number  of shares  held  by  such  shareholder,  or
distribute  the  shareholder's  votes  on  the  same  principle  among  as  many
candidates as the shareholder may select, provided that votes cannot be cast for
more than four candidates. No shareholder  or proxy, however, shall be  entitled
to  cumulate votes for a candidate unless  such candidate's name has been placed
in nomination prior to the voting and the shareholder, or any other shareholder,
has given  notice at  the meeting,  prior to  the voting,  of the  shareholder's
intention  to  cumulate  votes.  If  any  shareholder  gives  such  notice,  all
shareholders may cumulate their votes for candidates in nomination.

QUORUM; ABSTENTIONS; BROKER NON-VOTES

    The required quorum for the transaction of business at the Annual Meeting is
a majority of the shares  of Common Stock issued  and outstanding on the  Record
Date.   Shares  that  are  votes  "For"  or  "Against"  are  treated  as  shares
"represented and voting" at the Annual  Meeting (the "Votes Cast") with  respect
to such matter.

    While  there is no definitive statutory  or case law authority in California
as to  the proper  treatment of  abstentions or  broker non-votes,  the  Company
believes  that  both  abstentions and  broker  non-votes should  be  counted for
purposes of determining the presence or absence of a quorum for the  transaction
of  business. The Company  further believes that  neither abstentions nor broker
non-votes should be counted as shares "represented and voting" with respect to a
particular matter for  purposes of determining  the total number  of Votes  Cast
with  respect to such  matters. In the  absence of controlling  precedent to the
contrary, the Company intends to treat abstentions and broker non-votes in  this
manner.  Accordingly, they will  not affect the determination  as to whether the
requisite majority of Votes Cast has been obtained for a particular matter.

REVOCABILITY OF PROXIES

    Any proxy given pursuant to this  solicitation may be revoked by the  person
giving  it at any time  before its use by  delivering to the Company (Attention:
Ernest  P.  Quinones,  Corporate   Controller,  Chief  Accounting  Officer   and
Treasurer)  a written notice  of revocation or  a duly executed  proxy bearing a
later date or by attending the meeting and voting in person.

SOLICITATION

    The cost of soliciting proxies will be borne by the Company. The Company  is
retaining  the services  of Corporate  Investor Communications,  Inc. to solicit
proxies for  a cost  of  approximately $5,000  plus out-of-pocket  expenses.  In
addition,   the  Company  may  reimburse   brokerage  firms  and  other  persons
representing beneficial  owners  of  shares for  their  expenses  in  forwarding
solicitation material to such
<PAGE>
beneficial  owners. Proxies  may also be  solicited by certain  of the Company's
directors, officers  and  regular employees,  without  additional  compensation,
personally or by telephone, telegram or facsimile.

DEADLINE FOR RECEIPT OF SHAREHOLDER PROPOSALS

    Proposals  of shareholders of the Company which are intended to be presented
by such shareholders at the Company's  1996 Annual Meeting of Shareholders  must
be  received by the Company  no later than December 22,  1995 in order that they
may be  included in  the proxy  statement and  form of  proxy relating  to  that
meeting.

RECORD DATE AND SHARE OWNERSHIP

    Shareholders  of  record at  the close  of  business on  March 31,  1995 are
entitled to notice of and to vote at the meeting. At the record date, 15,407,095
shares of the Company's Common Stock, no par value, were issued and outstanding.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

    The following  table sets  forth certain  information known  to the  Company
regarding  beneficial ownership  of the Company's  Common Stock as  of March 31,
1995 (except as otherwise noted), by  (i) each of the Company's directors,  (ii)
each executive officer named in the Summary Compensation Table appearing herein,
(iii)  all directors and executive  officers of the Company  as a group and (iv)
each person  known by  the  Company to  beneficially own  more  than 5%  of  the
Company's Common Stock:

<TABLE>
<CAPTION>
                                                                               NUMBER OF     PERCENTAGE OF
NAME OF BENEFICIAL OWNER                                                      SHARES (1)      CLASS OWNED
- - ----------------------------------------------------------------------------  -----------  -----------------
<S>                                                                           <C>          <C>
William W.R. Elder** (2)....................................................      370,599           2.4%
Todd S. Myhre** (3).........................................................      108,328           *
William D. Cole** (4).......................................................       35,115           *
John E. Aldeborgh** (5).....................................................       21,383           *
Kevin C. Conlon** (6).......................................................       85,774           *
H. Vaughan Blaxter III*** (7)...............................................       21,250           *
Steve Fisher*** (8).........................................................            0           *
Mario M. Rosati*** (9)......................................................       56,299           *
Bachow Investment Partners III, L.P. (10)...................................      977,876           6.3
3 Bala Plaza East, Suite 502
Bala Cynwyd, PA 19004
Paul S. Bachow Co-Investment Fund, L.P. (11)................................      138,671           *
3 Bala Plaza East, Suite 502
Bala Cynwyd, PA 19004
Paul S. Bachow (12).........................................................       63,392           *
3 Bala Plaza East, Suite 502
Bala Cynwyd, PA 19004
The Parnassus Fund..........................................................    1,000,000           6.5
244 California Street, Suite 400
San Francisco, CA 94111
All directors and executive officers as a group (10 persons) (13)...........      698,748           4.4
<FN>
- - ------------------------
  *  Less than 1%

 **  Executive officer.

***  Non-employee director.

 (1) The  persons named in the table have  sole voting and investment power with
     respect to all shares of Common Stock shown as beneficially owned by  them,
     subject  to community  property laws  where applicable  and the information
     contained in the footnotes to this table.
</TABLE>

                                       2
<PAGE>
<TABLE>
<S>  <C>
 (2) Includes options to  purchase 190,000  shares of  Common Stock  exercisable
     within 60 days of March 31, 1995.

 (3) Includes  options to  purchase 108,328  shares of  Common Stock exercisable
     within 60 days of March 31, 1995.

 (4) Includes options  to purchase  29,997 shares  of Common  Stock  exercisable
     within 60 days of March 31, 1995.

 (5) Includes  options  to purchase  18,966 shares  of Common  Stock exercisable
     within 60 days of March 31, 1995.

 (6) Includes options  to purchase  56,665 shares  of Common  Stock  exercisable
     within 60 days of March 31, 1995.

 (7) Does  not include 346,119 shares held by affiliates of Henry L. Hillman, as
     to which Mr.  Blaxter disclaims beneficial  ownership. Includes options  to
     purchase  2,500 shares of Common Stock  exercisable within 60 days of March
     31, 1995.  Mr.  Blaxter,  a director  since  1991,  is not  a  nominee  for
     re-election.

 (8) On April 3, 1995, pursuant to the terms of a Stock Purchase Agreement dated
     February 10, 1995 (the "Stock Purchase Agreement") by and among the Company
     and  Bachow  Investment Partners  III, L.P.,  Paul S.  Bachow Co-Investment
     Fund, L.P.  and Paul  S.  Bachow, (collectively  the "Bachow  Group"),  Mr.
     Fisher  was elected  as a  representative of  the Bachow  Group to  fill an
     existing vacancy on the Company's Board of Directors. This figure does  not
     include  the 1,178,967 shares held by the  Bachow Group, as to which shares
     Mr. Fisher has neither voting nor investment power.

 (9) Includes options  to purchase  21,250 shares  of Common  Stock  exercisable
     within 60 days of March 31, 1995.

(10) Does  not include 138,671 shares held by Paul S. Bachow Co-Investment Fund,
     L.P. and  63,392  shares  held  by  Paul S.  Bachow,  as  to  which  Bachow
     Investment Partners III, L.P. disclaims beneficial ownership.

(11) Does  not include  977,876 shares held  by Bachow  Investment Partners III,
     L.P. and 63,392 shares held by Paul  S. Bachow, as to which Paul S.  Bachow
     Co-Investment Fund, L.P. disclaims beneficial ownership.

(12) Does  not include  977,876 shares held  by Bachow  Investment Partners III,
     L.P. and 138,671 shares held by Paul S. Bachow Co-Investment Fund, L.P., as
     to which Paul S. Bachow disclaims beneficial ownership.

(13) Includes options to  purchase 448,740  shares of  Common Stock  exercisable
     within 60 days of March 31, 1995.
</TABLE>

                                       3
<PAGE>
                             ELECTION OF DIRECTORS

NOMINEES

    The  Company's  Bylaws  provide  for  a  variable  board  of  four  to seven
directors, with the number currently fixed at  five. It is planned that a  board
of  four directors will be elected at the meeting and, thereafter, the number of
fixed directors will be reduced to four. Unless otherwise instructed, the  proxy
holder  will vote the  proxies received by  him for the  Company's four nominees
named below, all of whom  are presently directors of  the Company. In the  event
that  any nominee of the Company is unable or declines to serve as a director at
the time of the Annual  Meeting, the proxies will be  voted for any nominee  who
shall  be designated by the  present Board of Directors  to fill the vacancy. In
the event that additional persons are  nominated for election as directors,  the
proxy  holder intends to  vote all proxies received  by him in  such a manner in
accordance with cumulative voting as will assure the election of as many of  the
nominees  listed below as possible, and, in such event, the specific nominees to
be voted for will be determined by the proxy holder. It is not expected that any
nominee listed below will be unable or will decline to serve as a director.  The
term of office of each person elected as a director will continue until the next
Annual  Meeting  of Shareholders  or until  his successor  has been  elected and
qualified.

    The names of  the nominees  of the  Company, and  certain information  about
them, are set forth below.

<TABLE>
<CAPTION>
                                                                                                       DIRECTOR
   NAME OF NOMINEE          AGE                           PRINCIPAL OCCUPATION                           SINCE
- - ----------------------      ---      ---------------------------------------------------------------  -----------
<S>                     <C>          <C>                                                              <C>
William W.R. Elder              56   Chairman and Chief Executive Officer of the Company                    1981
Todd S. Myhre                   50   President, Chief Operating Officer and Acting Chief Financial          1994
                                      Officer of the Company
Steve Fisher                    42   Managing Director of Bachow & Associates, Inc.                         1995
Mario M. Rosati                 48   Member of Wilson, Sonsini, Goodrich & Rosati, Professional             1981
                                      Corporation
</TABLE>

    Except  as set  forth below, each  of the  nominees has been  engaged in his
principal occupation set forth  above during the past  five years. There are  no
family relationships among any directors or executive officers of the Company.

    Mr.  Elder, a founder of the Company,  served as President and as a director
of the Company  from its organization  in November 1981  through April 1990.  In
April  1990, he was named  Chairman of the Board,  President and Chief Executive
Officer. Mr. Elder currently serves as Chairman of the Board and Chief Executive
Officer of the Company.

    Mr. Myhre joined  the Company in  January 1993 as  Vice President and  Chief
Financial  Officer.  From August  1993  to December  1993,  Mr. Myhre  served as
Executive Vice President and Chief Operating Officer of the Company. In  January
1994,  Mr. Myhre was named  President and elected as  a director of the Company.
From April 1989 to  December 1992, Mr.  Myhre was President  and CFO of  Optimal
Associates, Inc., a real estate development company. From December 1988 to April
1989,  he was associated with Apple  Computer, Inc., a computer manufacturer, as
Worldwide Manufacturing Financial Director. From November 1977 to November 1988,
he served in various management positions at Hewlett-Packard Company, a computer
and instrumentation manufacturer, most recently as Group Operations Controller.

    Mr. Fisher has served as a director since April 3, 1995, when he was elected
pursuant  to  the  terms  of  the  Stock  Purchase  Agreement  to  serve  as   a
representative  of the Bachow Group by filling an existing vacancy on the Board.
He has been the  Managing Director of Bachow  & Associates, Inc., an  investment
firm,  since  June 1993.  For more  than five  years prior  to joining  Bachow &
Associates, Inc., he served in  numerous executive capacities with  Westinghouse
Broadcasting Company, Inc., a media and communications company, most recently as
Executive Vice President. He is also a director of DataMap, Inc.

                                       4
<PAGE>
    Mr.  Rosati  has been  Secretary and  a  director of  the Company  since the
Company's inception in November  1981. He is also  a director of C-ATS  Software
Inc.,   a  supplier  of  client/server  software  products  for  financial  risk
management; Meridian Data, Inc.,  a developer of  compact disc-read only  memory
(CD-ROM)  and compact  disc-recordable (CD-R)  systems and  related software for
both networks and  personal computers;  and Ross  Systems, Inc.,  a supplier  of
enterprise-wide  business systems  and related services  to companies installing
open systems/client server software products. He is a member of Wilson, Sonsini,
Goodrich & Rosati, Professional Corporation, general counsel to the Company.

VOTE REQUIRED

    The four nominees receiving the highest  number of affirmative votes of  the
shares  entitled  to be  voted for  them  shall be  elected as  directors. Votes
withheld from any director are counted for purposes of determining the  presence
or  absence of a  quorum, but have  no legal effect  under California law. While
there is no definitive statutory or case  law authority in California as to  the
proper  treatment  of  abstentions  and  broker  non-votes  in  the  election of
directors, the  Company  believes that  both  abstentions and  broker  non-votes
should be counted for purposes of determining whether a quorum is present at the
Annual Meeting. In the absence of precedent to the contrary, the Company intends
to  treat  abstentions and  broker  non-votes with  respect  to the  election of
directors in this manner.

BOARD MEETINGS AND COMMITTEES

    The Board of Directors of the Company  held a total of four meetings  during
the  year ended December 31, 1994. The Board of Directors has an Audit Committee
and a  Compensation Committee.  It does  not have  a nominating  committee or  a
committee performing the functions of a nominating committee.

    During  the year ended December 31, 1994 the Audit Committee of the Board of
Directors consisted of directors H. Vaughan Blaxter III and Rosati and held  one
meeting. As of March 31, 1995 the Audit Committee consisted of directors Blaxter
and   Rosati.  The  Audit  Committee  recommends  engagement  of  the  Company's
independent accountants and is primarily responsible for approving the  services
performed  by  the  Company's  independent  accountants  and  for  reviewing and
evaluating the  Company's  accounting  principles and  its  system  of  internal
accounting controls.

    During  the year ended  December 31, 1994 the  Compensation Committee of the
Board of Directors  consisted of  directors Blaxter  and Rosati  and held  three
meetings. As of March 31, 1995 the Compensation Committee consisted of directors
Blaxter  and  Rosati. The  Compensation Committee  makes recommendations  to the
Board of Directors  regarding the Company's  executive compensation policy.  See
"Compensation Committee Report on Executive Compensation."

    No  director serving in the year ended December 31, 1994 attended fewer than
75% of the aggregate number of meetings  of the Board of Directors and  meetings
of the committees of the Board on which he or she serves.

DIRECTOR COMPENSATION

    The  Company currently pays to its directors  who are not employees a fee of
$1,000 per meeting and $500 per telephonic meeting. The Company also  reimburses
directors  for  reasonable expenses  incurred in  attending meetings.  Under the
Company's 1991  Option Plan,  each  of the  non-employee directors  receives  an
automatic  grant of an  option to purchase  5,000 shares of  Common Stock on the
date of his or her appointment or election  to the Board and, for so long as  he
or  she continues  to serve as  a director, an  automatic grant of  an option to
purchase 5,000 shares of Common Stock on February 7 of each year. See "Amendment
of 1991 Incentive Stock Option Plan."

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

    In 1994,  the Company  paid  legal fees  and  expenses to  Wilson,  Sonsini,
Goodrich  & Rosati,  Professional Corporation,  general counsel  to the Company.
Mario M. Rosati, a  director and Secretary  of the Company, is  a member of  the
firm of Wilson, Sonsini, Goodrich & Rosati, Professional Corporation.

                                       5
<PAGE>
TRANSACTIONS WITH MANAGEMENT

    In  February 1992,  the Company loaned  William W.R. Elder,  Chairman of the
Board and Chief Executive  Officer of the Company,  $100,000 under a  three-year
note  bearing interest at 7% annually in  connection with the exercise by him of
options to purchase  80,000 shares of  Common Stock. Mr.  Elder's obligation  to
repay this loan is secured by the Common Stock received by him upon the exercise
of these options. This loan was extended to May 31, 1995 under the same terms.

    The  Board of Directors has  considered, and may consider  in the future, an
arrangement under which the  Company would make  payments to executive  officers
and  other employees in the event of  termination of their employment related to
any change in control of the Company.

    See also  "Compensation  Committee  Interlocks  and  Insider  Participation"
above.

SECTION 16(A) REPORTS

    Section  16(a) of the Securities Exchange Act of 1934 requires the Company's
officers and directors, and persons who own more than 10% of a registered  class
of  the Company's equity securities, to file certain reports regarding ownership
of, and  transactions  in, the  Company's  Securities with  the  Securities  and
Exchange  Commission (the "SEC"). Such  officers, directors and 10% shareholders
are also required by SEC rules to furnish the Company with copies of all Section
16(a) forms that they file.

    Based solely on its review  of the copies of such  forms received by it,  or
written  representations from  certain reporting  persons, the  Company believes
that during fiscal 1994 all Section 16(a) filing requirements applicable to  its
officers, directors and 10% shareholders were complied with without exception.

                       COMPENSATION OF EXECUTIVE OFFICERS

SUMMARY COMPENSATION TABLE

    The  following table discloses compensation  received by the Company's Chief
Executive Officer  and  the four  remaining  most highly  compensated  executive
officers of the Company for the three fiscal years ended December 31, 1994:

<TABLE>
<CAPTION>
                                                                                      LONG-TERM
                                                                                     COMPENSATION
                                                          ANNUAL COMPENSATION         AWARDS (2)
                                                      ---------------------------  ----------------       ALL OTHER
NAME AND PRINCIPAL POSITION                 YEAR      SALARY ($)    BONUS ($)(1)   OPTIONS/SARS (#)  COMPENSATION ($)(3)
- - --------------------------------------  ------------  -----------  --------------  ----------------  -------------------
<S>                                     <C>           <C>          <C>             <C>               <C>
William W.R. Elder,                          1994     $   260,000  $    53,950            --              $   7,980
 Chairman of the Board                       1993         216,667        --               --                  3,119
 and Chief Executive Officer                 1992         260,000        --               20,000              4,377
Todd S. Myhre                                1994     $   200,000  $    41,500            75,000          $   5,600
 President, Chief Operating                  1993(4)      149,426        --              125,000             --
 Officer and Acting Chief
 Financial Officer
William D. Cole                              1994     $   135,938  $   100,232(5)         20,000          $   3,365
 Vice President, Sales                       1993(4)      122,750       48,344(5)         35,000             --
John E. Aldeborgh                            1994     $   138,490  $    27,639            20,000          $   3,828
 Vice President and                          1993         123,860        --               --                 --
 General Manger,                             1992         114,535        --               20,000             --
 Ion Division.
Kevin C. Conlon                              1994     $   129,900  $    36,255(6)         15,000          $   3,412
 Vice President,                             1993         113,792        --               --                 --
 Marketing                                   1992          80,461       24,000            60,000             --
<FN>
- - ------------------------
(1)  Except  as otherwise noted, all bonuses were earned by the named officer in
     fiscal 1994 pursuant to the  Company's Management Incentive Plan, but  were
     not paid until fiscal 1995.
</TABLE>

                                       6
<PAGE>
<TABLE>
<S>  <C>
(2)  The  Company  did not  make  any awards  of  restricted stock  or  make any
     payments under long-term incentive plans during the periods covered in  the
     table.

(3)  Represents  amounts contributed to the  Company's 401(k) plan and/or profit
     sharing plan  on behalf  of the  officer by  the Company  in the  following
     amounts:  $6,240 to the profit sharing plan  for benefit of Mr. Elder; $800
     and $4,800 to the  401(k) plan and profit  sharing plan, respectively,  for
     benefit of Mr. Myhre; $102 and $3,263 to the 401(k) plan and profit sharing
     plan,  respectively, for benefit of Mr. Cole; $504 and $3,324 to the 401(k)
     plan and profit sharing plan,  respectively, for benefit of Mr.  Aldeborgh;
     and   $294  and  $3,118  to  the  401(k)  plan  and  profit  sharing  plan,
     respectively, for benefit of Mr. Conlon.  Premiums in the amount of  $1,740
     were  also paid  by the  Company on  behalf of  Mr. Elder  for a  term life
     insurance  policy  (the  proceeds  of  which  are  payable  to  his   named
     beneficiaries) in fiscal 1994.

(4)  Messrs.  Myhre and Cole  were not employed  by the Company  prior to fiscal
     1993.

(5)  Includes sales commissions earned by Mr.  Cole in the amount of $94,089  in
     fiscal 1994 and $48,344 in fiscal 1993.

(6)  Includes  $15,000 earned  by, and  paid to,  Mr. Conlon  in fiscal  1994 in
     connection with a non-recurring bonus arrangement.
</TABLE>

OPTION/SAR GRANTS IN LAST FISCAL YEAR

    The following table  provides information  on option grants  made in  fiscal
1994 to the named executive officers:

<TABLE>
<CAPTION>
                                                               INDIVIDUAL GRANTS                       POTENTIAL REALIZABLE
                                            --------------------------------------------------------     VALUE AT ASSUMED
                                                              % OF TOTAL                              ANNUAL RATES OF STOCK
                                                             OPTIONS/SARS                             PRICE APPRECIATION FOR
                                                              GRANTED TO     EXERCISE OR                 OPTION TERM (3)
                                             OPTIONS/SARS    EMPLOYEES IN    BASE PRICE   EXPIRATION  ----------------------
NAME                                        GRANTED (#)(1)  FISCAL YEAR (2)    ($/SH)        DATE      5% ($)      10% ($)
- - ------------------------------------------  --------------  ---------------  -----------  ----------  ---------  -----------
<S>                                         <C>             <C>              <C>          <C>         <C>        <C>
William W.R. Elder........................        --              --             --           --         --          --
Todd S. Myhre.............................        75,000            19.6      $    4.00    5/23/99    $  82,884  $   183,153
William D. Cole...........................        20,000             5.2      $    4.00    5/23/99    $  22,103  $    48,841
John E. Aldeborgh.........................        20,000             5.2      $    4.00    5/23/99    $  22,103  $    48,841
Kevin C. Conlon...........................        15,000             3.9      $    4.00    5/23/99    $  16,577  $    36,631
<FN>
- - ------------------------
(1)  The indicated options were granted on May 23, 1994, vest at rate of 1/3 per
     year and become fully exercisable on May 23, 1997.

(2)  The  Company granted  options to  purchase 382,800  shares to  employees in
     fiscal 1994.

(3)  Potential realizable value assumes that the stock price increases from  the
     date of grant until the end of the option term (5 years) at the annual rate
     specified (5% and 10%). Annual compounding results in total appreciation of
     28% (at 5% per year) and 61% (at 10% per year). The assumed annual rates of
     appreciation  are specified in SEC rules and do not represent the Company's
     estimate or  projection  of  future  stock  price.  The  Company  does  not
     necessarily  agree that this method can  properly determine the value of an
     option.
</TABLE>

                                       7
<PAGE>
AGGREGATED OPTION/SAR EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END
OPTION/SAR VALUES

    The  following table provides information  on option/SAR exercises in fiscal
1994 by the named executive officers and the value of such officers' unexercised
options/SARs at December 31, 1994.

<TABLE>
<CAPTION>
                                                                   NUMBER OF UNEXERCISED     VALUE OF UNEXERCISED IN-THE-
                                                                      OPTIONS/SARS AT           MONEY OPTIONS/SARS AT
                                         SHARES                        12/31/94 (#):               12/31/94 ($)(2):
                                       ACQUIRED ON     VALUE     --------------------------  ----------------------------
NAME                                   EXERCISE (#) REALIZED (1) EXERCISABLE  UNEXERCISABLE   EXERCISABLE   UNEXERCISABLE
- - -------------------------------------  -----------  -----------  -----------  -------------  -------------  -------------
<S>                                    <C>          <C>          <C>          <C>            <C>            <C>
William W.R. Elder...................      --           --           183,332         6,668   $   1,215,827   $    34,173
Todd S. Myhre........................      --           --            41,665       158,335   $     229,678   $   759,384
William D. Cole......................      --           --            11,666        43,334   $      56,872   $   193,753
John E. Aldeborgh....................       26,956   $  87,550         5,334        27,266   $      23,336   $   117,313
Kevin C. Conlon......................      --           --            39,999        35,001   $     223,743   $   171,882
<FN>
- - ------------------------
(1)  Market value of  underlying securities based  on the closing  price of  the
     Company's  Common  Stock  on The  Nasdaq  National  Market on  the  date of
     exercise, minus the exercise price.
(2)  Market value  of  underlying  securities  based on  the  closing  price  of
     Company's  Common Stock on December 30,  1994 on The Nasdaq National Market
     of $8.00 (less the exercise price).

     The Company  has not  established any  long-term incentive  plans,  defined
     benefit or actuarial plans, or arrangements relating to a change-in-control
     covering any of the named executive officers.
</TABLE>

            COMPENSATION COMMITTEE REPORT ON EXECUTIVE COMPENSATION

    The objectives of the overall executive compensation program are to attract,
retain,  motivate and  reward Company  executives while  aligning their relative
compensation with the achievements of  key business objectives, maximization  of
shareholder value and optimal satisfaction of customers.

    The Compensation Committee is responsible for:

    1.   Determining the specific executive  compensation vehicles to be used by
       the Company and the participants in each of those specific programs;

    2.  Determining the evaluation criteria  and timeliness to be used in  those
       programs;

    3.    Determining  the  processes  that  will  be  followed  in  the ongoing
       administration of the programs; and

    4.  Determining their role in the administration of the programs.

    All of the actions  take the form  of recommendations to  the full Board  of
Directors  where  final  approval,  rejection  or  redirection  will  occur. The
Compensation  Committee  is  responsible  for  administering  the   compensation
programs  for all Company officers. The Compensation Committee has delegated the
responsibility of administering the compensation programs for all other  Company
employees to the Company's officers.

    Currently, the Company uses the following executive compensation vehicles:

    - Cash-based  programs:  base  salary,  Management  Incentive  Plan,  Profit
      Sharing Plan, and a Sales Incentive Commission Plan; and

    - Equity-based programs:  1991  Incentive Stock  Option  Plan and  the  1989
      Employee Stock Purchase Plan.

    These  programs apply to the Chief Executive Officer and all executive level
positions, except for the Sales  Incentive Commission Plan, which only  includes
executives directly responsible for sales activities. Periodically, but at least
once  near the close of each fiscal year, the Compensation Committee reviews the
existing plans and recommends those that should be used for the subsequent year.

    The criteria for determining the  appropriate salary level, bonus and  stock
option grants for the Chief Executive Officer and each of the executive officers
include (a) Company performance as a

                                       8
<PAGE>
whole,  (b)  business unit  performance (where  appropriate) and  (c) individual
performance objectives. Company  performance and business  unit performance  are
measured against both strategic and financial goals. Examples of these goals are
to  obtain: operating profit,  revenue growth, timely  new product introduction,
and shareholder value (usually measured by the Company stock price).  Individual
performance  is  measured to  specific objectives  relevant to  the individual's
position and a specific time frame.

    The above criteria  are usually related  to a fiscal  year time period,  but
may, in some cases, be measured over a shorter or longer time frame.

    The  processes  used by  the  Compensation Committee  include  the following
steps:

    1.  The Compensation  Committee periodically receives information  comparing
       the  Company's pay levels to other companies in similar industries, other
       leading companies  (regardless of  industry) and  competitors.  Primarily
       national and regional compensation surveys are used.

    2.    At  or near  the  start  of each  evaluation  cycle,  the Compensation
       Committee meets with the Chief Executive Officer and the Chief  Operating
       Officer  to  review,  revise  as needed,  and  agree  on  the performance
       objectives set for the other executives reporting to the Chief  Executive
       Officer  and the  Chief Operating  Officer. The  Chief Executive Officer,
       Chief Operating  Officer  and  Compensation  Committee  jointly  set  the
       Company   objectives  to  be  used.  The  business  unit  and  individual
       objectives are formulated jointly by the Chief Executive Officer or Chief
       Operating Officer and the specific individual. The Compensation Committee
       also, with the  Chief Executive  Officer or Chief  Operating Officer,  as
       appropriate,   jointly  establishes   and  agrees   on  their  respective
       performance objectives.

    3.  Throughout  the performance cycle  review, feedback is  provided by  the
       Chief  Executive Officer,  the Chief Operating  Officer, the Compensation
       Committee and full Board, as appropriate.

    4.  At the  end of the  performance cycle, the  Chief Executive Officer  and
       Chief  Operating Officer  evaluate each  executive's relative  success in
       meeting the  performance goals.  The Chief  Executive Officer  and  Chief
       Operating  Officer  make  recommendations  on  salary,  bonus  and  stock
       options, utilizing the external comparative results, as provided in No. 1
       above, as a factor. Also included in the decision criteria are subjective
       factors such as teamwork, leadership contributions and ongoing changes in
       the business climate.  The Chief  Executive Officer  and Chief  Operating
       Officer  review their recommendations with the Compensation Committee and
       obtain its  approval.  The  Compensation Committee  also  determines  the
       salary,  bonus and terms  of stock option grants  for the Chief Executive
       Officer and Chief Operating Officer.

    5.  The final evaluations and compensation decisions are discussed with each
       executive by  the Chief  Executive Officer,  Chief Operating  Officer  or
       Compensation Committee, as appropriate.

    The  Compensation Committee feels that the compensation vehicles used by the
Company, generally administered through the process as outlined above, provide a
fair and balanced executive compensation program related to the proper  business
issues.  In  addition, it  should be  noted that  compensation vehicles  will be
reviewed and,  as  appropriate, revised  in  order  to attract  and  retain  new
executives in addition to rewarding performance on the job.

                                          Respectfully submitted by:

                                          H. Vaughan Blaxter III
                                          Mario M. Rosati

                                       9
<PAGE>
                               PERFORMANCE GRAPH

    The  following  graph shows  a  comparison of  cumulative  total shareholder
return, calculated on  a dividend reinvested  basis, from the  last trading  day
before  the  beginning of  the Company's  1990 Fiscal  Year (December  31, 1989)
through 1994 Fiscal Year End for each of the Company, The Nasdaq Stock Market-US
Index and the Hambrecht  & Quist Technology Index.  The graph assumes that  $100
was  invested on December 31, 1989 in  the Company's Common Stock at fair market
value, in  The  Nasdaq  Stock Market-US  Index  and  in the  Hambrecht  &  Quist
Technology  Index. Note that historic stock price performance is not necessarily
indicative of future stock price performance.

                COMPARISON OF FIVE YEAR CUMULATIVE TOTAL RETURN*
              AMONG GENUS, INC., THE NASDAQ STOCK MARKET-US INDEX
                   AND THE HAMBRECHT & QUIST TECHNOLOGY INDEX

EDGAR REPRESENTATION OF DATA POINTS USED IN PRINTED GRAPHIC

<TABLE>
<CAPTION>
            GENUS, INC.     THE NASDAQ STOCK MARKET-US         H&Q TECHNOLOGY
<S>        <C>             <C>                          <C>
12/89                 100                          100                    100
12/90                  16                           85                     91
12/91                  46                          135                    136
12/92                  34                          159                    155
12/93                  38                          181                    170
12/94                 102                          177                    197
</TABLE>

- - ------------------------

*   The total  return on each of these  investments assumes the reinvestment  of
    dividends,  although dividends have never been  paid on the Company's Common
    Stock. The Company's fiscal year ends on December 31.

                 AMENDMENT OF 1991 INCENTIVE STOCK OPTION PLAN

GENERAL

    The 1991 Incentive Stock Option Plan ("1991 Option Plan") was adopted by the
Board of Directors in February 1991. Prior to January 1995, a total of 1,553,006
shares of Common Stock were reserved  for issuance thereunder. In January  1995,
the Board of Directors approved an amendment to the 1991 Option Plan to increase
the number of shares of Common Stock reserved for issuance thereunder by 500,000
to 2,053,006 shares. Management recommends that the shareholders vote to approve
this amendment of the 1991 Option Plan.

    All  employees,  including officers  and directors,  and consultants  of the
Company or any of its designated subsidiaries are eligible to be granted options
under the 1991 Option Plan. In addition,

                                       10
<PAGE>
non-employee directors (the "Outside Directors") are eligible for option  grants
under  the  Automatic Grant  Plan described  below.  As of  March 31,  1995, 283
full-time employees (including officers  and directors), 28 part-time  employees
and 9 consultants were eligible for grants under the 1991 Option Plan, while two
non-employee directors were eligible for grants under the Automatic Grant Plan.

    Options  granted under the  1991 Option Plan may  be either "incentive stock
options," as defined in  Section 422 of  the Internal Revenue  Code of 1986,  as
amended  (the "Code"), or "nonstatutory options."  As of March 31, 1995, options
to purchase 1,477,858 shares had  been exercised, options to purchase  1,583,173
shares  were outstanding and 28,413 shares  were available for future grant. The
closing price of  the Company's  Common Stock  reported on  The Nasdaq  National
Market  on March 31, 1995,  was $10.50 per share.  The essential features of the
1991 Option Plan are outlined below.

PARTICIPATION OF OFFICERS AND DIRECTORS IN THE OPTION PLAN

    The grant of options under the Option Plan to executive officers,  including
the  officers named in the Summary Compensation Table (the "Named Officers"), is
subject to the discretion of the Board. As of the date of this proxy  statement,
there has been no determination by the Board with respect to future awards under
the  Option Plan. Accordingly, future awards  are not determinable. The table of
option  grants  under  the  caption  "Compensation  of  Executive  Officers   --
Option/SAR  Grants in Last Fiscal Year" provides information with respect to the
grant of options to the Named Officers during the Last Fiscal Year.  Information
regarding  options  granted to  Outside Directors  during  the Last  Fiscal Year
pursuant to the Automatic Grant Program is set forth under the heading "Election
of  Directors  --  Director  Compensation."  The  following  table  sets   forth
additional  information with respect  to options granted  during the Last Fiscal
Year to certain other groups:

<TABLE>
<CAPTION>
                                                                                       WEIGHTED AVERAGE
                                                                            OPTIONS     EXERCISE PRICE
IDENTITY OF GROUP                                                         GRANTED (#)      PER SHARE
                                                                          -----------  -----------------
<S>                                                                       <C>          <C>
All current executive officers as a group...............................     157,500       $   4.00
All employees as a group (excludes executive officers)..................     225,300       $   4.44
</TABLE>

PURPOSE

    The 1991  Option Plan  replaced the  1981 Option  Plan which  terminated  in
December  1991. The purposes of  the 1991 Option Plan  are to attract and retain
the best available  personnel for  positions of  substantial responsibility,  to
provide  additional  incentive  and  to promote  the  success  of  the Company's
business.

ADMINISTRATION

    The 1991 Option Plan provides for  administration by the Board of  Directors
of the Company or by a committee of the Board. The 1991 Option Plan is currently
being  administered by the Compensation Committee of the Board of Directors (the
"Compensation Committee"),  which is  consisted of  Outside Directors  only.  No
member  of the Compensation Committee who is eligible to participate in the plan
may vote  on  any  option  to  be  granted  to  himself  or  take  part  in  any
consideration   of  the  1991  Option  Plan   as  it  applies  to  himself.  The
interpretation and construction of any provision of the 1991 Option Plan by  the
Compensation   Committee  shall  be   final  and  conclusive.   Members  of  the
Compensation Committee receive no compensation for their services in  connection
with the administration of the 1991 Option Plan.

ELIGIBILITY

    The  1991 Option  Plan provides  that options  may be  granted to employees,
including officers and directors, and consultants  of the Company or any of  its
designated   subsidiaries.  Except  with  respect   to  Outside  Directors,  the
Compensation Committee selects the optionees and determines the number of shares
to be  subject to  each option  and the  time or  times at  which shares  become
exercisable  under  the option.  In making  such  determination, the  duties and
responsibilities of  the  employee  or  consultant, the  value  of  his  or  her
services,  his or her present  and potential contribution to  the success of the

                                       11
<PAGE>
Company, the anticipated number  of years of future  service and other  relevant
factors  are taken  into account.  There is  a $100,000  limit on  the aggregate
market value  of  shares  subject  to all  incentive  stock  options  which  are
exercisable for the first time in any one calendar year.

    The 1991 Option Plan, as amended by the Board of Directors in February 1994,
limits the discretion of the Compensation Committee in granting stock options to
certain individuals. This limitation provides that no officer or employee may be
granted  in any one  fiscal year stock  options under the  1991 Option Plan with
respect to more than 400,000 shares of Common Stock. This limitation is intended
to preserve the Company's ability to deduct for federal income tax purposes  the
compensation  expense relating to  stock options and  purchase rights granted to
certain executive officers under the 1991 Option Plan. Without this  limitation,
the  federal tax legislation enacted in August  1993 might not allow the Company
to deduct such compensation expense.

    The August  1993 federal  tax legislation  imposed limits  on the  Company's
ability  to deduct  compensation paid  to certain  of the  Company's current and
future executive officers.  However, these limitations  on deductibility do  not
apply to compensation attributable to stock options or purchase rights if, among
other  things, the plan under which the  options or purchase rights were granted
includes a limit on the discretion to make grants. The limitation on  discretion
contained  in the 1991 Option  Plan is intended to  meet this requirement. Since
the limitation has  been included solely  to preserve the  Company's ability  to
deduct  such compensation, the  Board of Directors may  modify or eliminate this
limitation if  it  is  not  required  to  preserve  the  deductibility  of  such
compensation.

OUTSIDE DIRECTORS' OPTIONS

    The  1991  Option Plan  provides that,  with  respect to  Outside Directors,
nonstatutory options shall be  automatically granted to  Outside Directors on  a
yearly  basis from their initial appointment or  election in order to provide an
incentive to Outside Directors of  the Company (the "Automatic Grant  Program").
The  exercise price of options granted under  the Automatic Grant Program is the
fair market value of  the Company's Common  Stock on the  date of the  automatic
grant.  Outside Directors may not be granted  options under the 1991 Option Plan
except under the Automatic Grant Program.

    Each Outside Director receives an automatic grant on the date of his or  her
appointment  or election  to the  Board of an  initial option  to purchase 5,000
shares of Common Stock and, for  as long as he or  she continues to serve as  an
Outside  Director, receives an automatic grant on  February 7 of each year of an
option to purchase  an additional 5,000  shares of Common  Stock. These  options
become  exercisable cumulatively with respect to 1/12th of the underlying shares
on the last day  of each month following  the date of grant  and have a term  of
five years from the date of grant.

TERMS OF OPTIONS

    The  terms of  the options  granted under the  1991 Option  Plan (other than
options granted to  Outside Directors  pursuant to the  Automatic Grant  Program
(the  "Outside Director Options")) are determined by the Compensation Committee.
Each option granted under the  1991 Option Plan is  evidenced by a stock  option
agreement  between the Company and  the employee to whom  such option is granted
and is subject to the following additional terms and conditions:

        (a) EXERCISE OF THE OPTION:  The Compensation Committee determines  when
    options  granted under  the 1991  Option Plan  (other than  Outside Director
    Options) may be exercised. An option  is exercised by giving written  notice
    of  exercise to the Company, specifying the  number of full shares of Common
    Stock to be purchased and tendering  payment to the Company of the  purchase
    price.  Payment for shares issued upon exercise  of an option may consist of
    cash, promissory note, exchange of shares  of the Company's Common Stock  or
    such  other consideration  as determined  by the  Board of  Directors or its
    committee and as permitted by the California Corporations Code.

        (b) OPTION PRICE:   The option price under  the 1991 Option Plan  (other
    than  Outside Director Options) is determined by the Compensation Committee.
    The option price may not be less than  100% of the fair market value of  the
    Company's Common Stock on the date the option is

                                       12
<PAGE>
    granted.  However,  in the  case of  incentive stock  options granted  to an
    optionee who owns more than 10% of the voting power or value of all  classes
    of  stock of the Company, the per share exercise price must not be less than
    110% of  the  fair market  value  on the  date  of grant.  The  Compensation
    Committee  determines such fair market value based upon the closing price of
    the Common Stock in  The Nasdaq National  Market on the  date the option  is
    granted.

        (c)  TERMINATION OF EMPLOYMENT:   The 1991 Option  Plan provides that if
    the optionee's employment by the Company is terminated for any reason  other
    than  death, options may  be exercised not  later than thirty  days (or such
    other period of  time not  exceeding three months  as is  determined by  the
    Compensation  Committee and  specified in  the option  agreement) after such
    termination and  may  be exercised  only  to  the extent  the  options  were
    exercisable on the date of termination.

        (d)  DEATH:  If an optionee should  die while employed by the Company or
    during  the  thirty-day  period  following  termination  of  the  optionee's
    employment, options may be exercised at any time within six months after the
    date  of death but only  to the extent that  the options were exercisable on
    the date of death or termination of employment, whichever is earlier.

        (e) TERMINATION OF OPTIONS:  Options granted under the 1991 Option  Plan
    (other  than  Outside Director  Options) expire  10 years  from the  date of
    grant, unless otherwise provided in the option agreement. However, incentive
    stock options granted to  an optionee who, immediately  before the grant  of
    such  option, owned more than 10% of  the total combined voting power of all
    classes of stock of the Company  or a parent or subsidiary corporation,  may
    not have a term of more than five years.

        (f)  NONTRANSFERABILITY OF OPTIONS:  An option is nontransferable by the
    optionee, other than by will or the laws of descent and distribution, and is
    exercisable only by the optionee during his or her lifetime or, in the event
    of death, by  a person  who acquires  the right  to exercise  the option  by
    bequest or inheritance or by reason of the death of the optionee.

        (g)  ACCELERATION OF OPTIONS:  In the event of a merger or consolidation
    in which the Company is not the surviving entity, the Compensation Committee
    is obligated to either accomplish a substitution of options or give 30 days'
    notice  of  the  acceleration  of  the  optionee's  right  to  exercise  his
    outstanding options in full at any time within 30 days of such notice.

        (h)  OTHER  PROVISIONS:   The option  agreement  may contain  such other
    terms, provisions and conditions not inconsistent with the 1991 Option  Plan
    as may be determined by the Compensation Committee.

ADJUSTMENT UPON CHANGES IN CAPITALIZATION

    In  the event any change, such as a  stock split or dividend, is made in the
Company's capitalization which results in an increase or decrease in the  number
of  outstanding shares of  Common Stock without receipt  of consideration by the
Company, an appropriate adjustment shall be made in the option price and in  the
number  of  shares  subject  to  each  option.  In  the  event  of  the proposed
dissolution or liquidation of the Company, all outstanding options automatically
terminate immediately prior to the consummation of such action unless  otherwise
provided  by the Compensation  Committee. The Compensation  Committee may in its
discretion make provision for accelerating the exercisability of shares  subject
to options under the 1991 Option Plan in such event.

AMENDMENT AND TERMINATION

    The  Board of Directors may  amend the 1991 Option Plan  at any time or from
time to time or may terminate it without approval of the shareholders, provided,
however, that shareholder approval is required for any amendment which increases
the number of shares which may be issued under the 1991 Option Plan,  materially
changes  the standards of eligibility or materially increases the benefits which
may accrue to participants under the 1991 Option Plan. However, no action by the
Board of Directors  or shareholders may  alter or impair  any option  previously
granted under the 1991 Option Plan without the consent of the affected optionee.
The 1991 Option Plan will terminate in 2001.

                                       13
<PAGE>
TAX INFORMATION

    Options  granted under the  1991 Option Plan may  be either "incentive stock
options," as defined in  Section 422 of  the Internal Revenue  Code of 1986,  as
amended (the "Code"), or nonstatutory options.

    An  optionee who  is granted  an incentive  stock option  will not recognize
taxable income either at the  time the option is  granted or upon its  exercise,
although  the exercise may subject the  optionee to the alternative minimum tax.
Upon the sale or exchange of the shares  more than two years after grant of  the
option  and  one year  after exercising  the option,  any gain  or loss  will be
treated as long-term  capital gain  or loss. If  these holding  periods are  not
satisfied,  the optionee will recognize  ordinary income at the  time of sale or
exchange equal to the difference between the exercise price and the lower of (i)
the fair market value of the shares at  the date of the option exercise or  (ii)
the  sale price of  the shares. A  different rule for  measuring ordinary income
upon such a premature disposition may apply if the optionee is also an  officer,
director,  or 10% shareholder of the Company.  The Company will be entitled to a
deduction in the same amount as the ordinary income recognized by the  optionee.
Any  gain or loss  recognized on such  a premature disposition  of the shares in
excess of  the  amount treated  as  ordinary  income will  be  characterized  as
long-term or short-term capital gain or loss, depending on the holding period.

    All  other  options which  do  not qualify  as  incentive stock  options are
referred to as nonstatutory options. An optionee will not recognize any  taxable
income  at  the time  he is  granted  a nonstatutory  option. However,  upon its
exercise, the optionee will recognize  taxable income generally measured as  the
excess  of the then fair market value  of the shares purchased over the purchase
price. Any taxable income recognized in connection with an option exercise by an
optionee who  is  also  an employee  of  the  Company will  be  subject  to  tax
withholding  by the  Company. Upon  resale of such  shares by  the optionee, any
difference between the  sales price and  the optionee's purchase  price, to  the
extent  not recognized as taxable income as  described above, will be treated as
long-term or short-term capital gain or loss, depending on the holding period.

    The Company will be entitled  to a tax deduction in  the same amount as  the
ordinary  income recognized by the Optionee with respect to shares acquired upon
exercise of a nonstatutory option.

    The foregoing is  only a summary  of the effect  of federal income  taxation
upon  the optionee  and the Company  with respect  to the grant  and exercise of
options under the 1991 Option  Plan, does not purport  to be complete, and  does
not  discuss the tax consequences of the optionee's death or the income tax laws
of any municipality, state or foreign country in which an optionee may reside.

VOTE REQUIRED

    Affirmative votes constituting a majority of the votes cast will be required
to approve  and  ratify  the  amendment of  the  1991  Option  Plan.  MANAGEMENT
RECOMMENDS  THAT THE SHAREHOLDERS VOTE FOR THE  APPROVAL OF THE AMENDMENT TO THE
1991 OPTION PLAN.

                 AMENDMENT OF 1989 EMPLOYEE STOCK PURCHASE PLAN

GENERAL

    The 1989 Employee Stock Purchase Plan  (the "Purchase Plan") was adopted  by
the  Board of Directors  in March 1989  and approved by  the shareholders in May
1990. In January 1995, the Board of Directors amended the Purchase Plan, subject
to shareholder  approval, to  increase  the number  of  shares of  Common  Stock
reserved  for issuance thereunder by 250,000 shares, from 1,050,000 to 1,300,000
shares. As of March 31, 1995, 833,624 shares had been issued under the  Purchase
Plan,  and  216,376 shares  remained available  for  future issuances  under the
Purchase Plan.

PURPOSE

    The purpose of the Purchase Plan is to provide employees of the Company (and
any of its  subsidiaries which  are designated by  the Board  of Directors)  who
participate in the Purchase Plan with an opportunity to purchase Common Stock of
the Company through payroll deductions.

                                       14
<PAGE>
ADMINISTRATION

    The  Purchase  Plan may  be  administered by  the  Board of  Directors  or a
committee appointed by the Board. All questions of interpretation or application
of the Purchase  Plan are  determined at  the sole  discretion of  the Board  of
Directors or its committee. The Purchase Plan is currently being administered by
the  Compensation Committee. Members of the  Board of Directors who are eligible
employees are permitted to participate in the Purchase Plan but may not vote  on
any matter affecting the administration of the Purchase Plan or the grant of any
option  pursuant to the Purchase Plan, or be a member of any committee appointed
to administer the Purchase  Plan. No charges for  administrative or other  costs
may  be made  against the  payroll deductions of  a participant  in the Purchase
Plan. Members of the Compensation  Committee receive no additional  compensation
for their services in connection with the administration of the Purchase Plan.

ELIGIBILITY

    Any  person who is  employed by the  Company (or by  any of its subsidiaries
which are designated from time to time  by the Board) for at least twenty  hours
per  week and more than  five months in a  calendar year on the  date his or her
participation in  the  plan is  effective  is  eligible to  participate  in  the
Purchase  Plan. As of March 31,  1995, approximately 260 employees were eligible
to participate in the Purchase Plan.

PARTICIPATION IN THE PURCHASE PLAN

    Eligible employees become participants in the Purchase Plan by delivering to
the Company a subscription agreement authorizing payroll deductions prior to the
applicable offering date. An employee who becomes eligible to participate in the
Purchase Plan after the commencement of  an offering may not participate in  the
Purchase Plan until the commencement of the next offering period.

    Outside  Directors are not eligible to participate in the Purchase Plan. The
participation of the  Named Officers  in the Purchase  Plan is  entirely at  the
election  of  each  individual  officer; accordingly,  future  benefits  are not
determinable. The following  table sets  forth information with  respect to  the
participation  under the Purchase  Plan of the Named  Officers and certain other
groups during fiscal 1994:

<TABLE>
<CAPTION>
                                                      NUMBER OF    AGGREGATE     AGGREGATE
                                                       SHARES      PURCHASE    MARKET VALUE    NET VALUE
IDENTITY OF PERSON OR GROUP                           PURCHASED      PRICE          (1)           (2)
                                                     -----------  -----------  -------------  ------------
<S>                                                  <C>          <C>          <C>            <C>
William W.R. Elder.................................      --           --            --             --
Todd S. Myhre......................................      --           --            --             --
William D. Cole....................................       5,118    $    2.66   $      29,478   $   15,885
John E. Aldeborgh..................................       5,715    $    2.42   $      30,879   $   17,030
Kevin C. Conlon....................................       5,392    $    2.41   $      28,763   $   15,775
All current executive officers as a group..........      19,580    $    2.49   $     107,937   $   59,230
All employees as a group (excludes executive
 officers).........................................     175,274    $    2.49   $   1,021,922   $  585,383
<FN>
- - ------------------------
(1)  The market value of the shares purchased  is based on the closing price  of
     the  Company's Common Stock  on The Nasdaq  National Market on  the date of
     purchase.

(2)  Market value, less the purchase price.
</TABLE>

OFFERING DATE

    The Purchase Plan  is implemented by  overlapping 24-month offering  periods
containing  four six-month purchase periods. New offering periods commence every
six months. The purchase periods generally commence  on July 1 and January 1  of
each  year. The Board  of Directors has the  power to alter  the duration of the
offering periods without shareholder approval.

                                       15
<PAGE>
PURCHASE PRICE

    The purchase price  per share at  which shares are  sold under the  Purchase
Plan  is the lower of 85% of fair  market value of the Company's Common Stock on
the date of  commencement of the  24-month offering  period or 85%  of the  fair
market  value of the  Company's Common Stock  on the first  day of the six-month
purchase  period.  Eligible  employees  are  automatically  re-enrolled  in  the
offering  period with the lower of 85% of  fair market value of the Common Stock
on the date of  commencement of such 24-month  offering period. The fair  market
value  of  the  Common  Stock  on  a  given  date  shall  be  determined  by the
Compensation Committee based upon the reported closing price of the Common Stock
on The Nasdaq National Market on such date.

PAYMENT OF PURCHASE PRICE; PAYROLL DEDUCTIONS

    The purchase price of the shares is accumulated by payroll deductions during
the offering  period. The  deductions  may not  exceed  10% of  a  participant's
eligible compensation. A participant may discontinue his or her participation in
the  Purchase  Plan or  may  decrease, but  not  increase, the  rate  of payroll
deductions at any time during the offering period.

    All payroll deductions are credited  to the participant's account under  the
Purchase  Plan and  are deposited  with the  general funds  of the  Company. All
payroll deductions received or held  by the Company may  be used by the  Company
for any corporate purpose.

PURCHASE OF STOCK; EXERCISE OF OPTION

    At  the  beginning  of each  offering  period, by  executing  a subscription
agreement to  participate in  the  Purchase Plan,  each  employee is  in  effect
granted  an option  to purchase  shares of Common  Stock. The  maximum number of
shares placed under  option to  a participant in  an offering  is determined  by
dividing  the compensation which  such participant has  elected to have withheld
during the offering period by 85% of  the fair market value of the Common  Stock
at  the beginning  of the  offering period  or beginning  of a  purchase period,
whichever is lower.

WITHDRAWAL

    While  each  participant  in  the  Purchase  Plan  is  required  to  sign  a
subscription   agreement  authorizing  payroll   deductions,  the  participant's
interest in a given  offering may be  terminated in whole, but  not in part,  by
signing  and delivering to the Company a  notice of withdrawal from the Purchase
Plan. Such  withdrawal may  be elected  at  any time  prior to  the end  of  the
applicable 24-month offering period. A participant's withdrawal from an offering
does  not have any effect upon  such participant's eligibility to participate in
subsequent offerings under the Purchase Plan.

TERMINATION OF EMPLOYMENT

    Termination  of  a  participant's  employment  for  any  reason,   including
retirement  or  death, cancels  his or  her participation  in the  Purchase Plan
immediately. In such event, the payroll deductions credited to the participant's
account will be returned to  such participant or, in the  case of death, to  the
person  or  persons  entitled  thereto  as  specified  by  the  employee  in the
subscription agreement.

CHANGES

    In the event of any change, such as stock splits or stock dividends, made in
the capitalization of the  Company which results in  an increase or decrease  in
the   number  of  shares   of  Common  Stock   outstanding  without  receipt  of
consideration by  the  Company, appropriate  adjustments  will be  made  by  the
Company  in the number of  shares subject to purchase  and in the purchase price
per share, subject to any required action by the shareholders of the Company.

AMENDMENT AND TERMINATION OF THE PLAN

    The Board of Directors may at any time amend or terminate the Purchase Plan,
except that such termination shall not affect options previously granted nor may
any amendment make any change in an option granted prior thereto which adversely
affects the rights of any participant. No amendment may be made to the  Purchase
Plan without approval of the shareholders of the Company if such amendment would
increase  the number of shares reserved  under the Purchase Plan, permit payroll

                                       16
<PAGE>
deductions  at  a  rate  in  excess  of  ten  percent  (10%)  of   participant's
compensation,  materially  modify  the  eligibility  requirements  or materially
increase the benefits which may accrue to participants under the Purchase  Plan.
The Purchase Plan will terminate in 2009.

TAX INFORMATION

    The  Purchase  Plan,  and  the  right  of  participants  to  make  purchases
thereunder, is intended to qualify under the provisions of Sections 421 and  423
of  the Code. Under these provisions, no income will be taxable to a participant
until the  shares  purchased under  the  Purchase  Plan are  sold  or  otherwise
disposed  of. Upon sale or other disposition of the shares, the participant will
generally be subject  to tax  and the  amount of the  tax will  depend upon  the
holding  period. If the shares  are sold or otherwise  disposed of more than two
years from the first day of the offering  period and one year from the date  the
shares are purchased, the participant will recognize ordinary income measured as
the  lesser of (a) the excess of the fair market value of the shares at the time
of such sale or disposition over the  purchase price, or (b) an amount equal  to
15%  of the fair market value of the shares  as of the first day of the offering
period. Any additional gain  will be treated as  long-term capital gain. If  the
shares  are sold or otherwise disposed of before the expiration of these holding
periods, the participant  will recognize ordinary  income generally measured  as
the  excess of the  fair market value of  the shares on the  date the shares are
purchased over the purchase price. Any additional  gain or loss on such sale  or
disposition  will be long-term or short-term  capital gain or loss, depending on
the holding period. The Company is not entitled to a deduction for amounts taxed
as ordinary income  or capital gain  to a  participant except to  the extent  of
ordinary  income recognized by participants upon a sale or disposition of shares
prior to the expiration of the holding period(s) described above.

    The foregoing is  only a summary  of the effect  of federal income  taxation
upon  the participant and the Company with respect to the shares purchased under
the Purchase Plan. Reference should be made to the applicable provisions of  the
Code.  In  addition, the  summary does  not  discuss the  tax consequences  of a
participant's death or the income  tax laws of any  state or foreign country  in
which the participant may reside.

REQUIRED VOTE

    The  approval of the amendment to the Purchase Plan requires the affirmative
vote of the holders of  a majority of the shares  of the Company's Common  Stock
entitled  to  vote  and  present  or  represented  at  the  meeting.  MANAGEMENT
RECOMMENDS THAT THE SHAREHOLDERS VOTE FOR  THE APPROVAL OF THE AMENDMENT TO  THE
PURCHASE PLAN.

             RATIFICATION OF APPOINTMENT OF INDEPENDENT ACCOUNTANTS

    The  Board  of Directors  has selected  Coopers  & Lybrand  LLP, independent
accountants, to  audit the  financial statements  of the  Company for  the  year
ending  December  31,  1995,  and  recommends  that  the  shareholders  vote for
ratification of  such appointment.  In the  event  of a  negative vote  on  such
ratification,  the Board of  Directors will reconsider  its selection. Coopers &
Lybrand LLP has audited the Company's financial statements since the year  ended
December  31, 1982. Representatives of Coopers &  Lybrand LLP are expected to be
present at the meeting with the opportunity  to make a statement if they  desire
to do so, and are expected to be available to respond to appropriate questions.

                                 OTHER MATTERS

    The Company knows of no other matters to be submitted to the meeting. If any
other  matters properly  come before  the meeting,  it is  the intention  of the
persons named in the enclosed form of Proxy to vote the shares they represent as
the Board of Directors may recommend.

                                          THE BOARD OF DIRECTORS

Dated: April 26, 1995

                                       17
<PAGE>

           THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
                                   GENUS, INC.
                       1995 ANNUAL MEETING OF SHAREHOLDERS

     The undersigned shareholder of GENUS, INC., a California corporation (the
"Company"), hereby acknowledges receipt of the Notice of Annual Meeting of
Shareholders and Proxy Statement, each dated April 26, 1995, and hereby appoints
Ernest P. Quinones proxy and attorney-in-fact, with full power of substitution,
on behalf and in the name of the undersigned, to represent the undersigned at
the 1995 Annual Meeting of Shareholders of GENUS, INC. to be held on Tuesday,
May 23, 1995, at 3:00 p.m., local time, at the Santa Clara Mariott Hotel located
at 2700 Mission College Boulevard, Santa Clara, California  95052 and any
continuation(s) or adjournment(s) thereof, and to vote all shares of Common
Stock which the undersigned would be entitled to vote if then and there
personally present, on the matters set forth below.

                                                                   -------------
                                                                    See Reverse
                                                                       Side
                                                                   -------------
<PAGE>

                                ------------------             /X/ Please mark
                                     COMMON                        your choice
                                                                    like this

     1.   Election of directors:

          ___  FOR all nominees listed below (except as indicated)

          ___  WITHHOLD authority to vote for all nominees listed below.

          IF YOU WISH TO WITHHOLD AUTHORITY TO VOTE FOR ANY INDIVIDUAL NOMINEE,
STRIKE A LINE THROUGH THAT NOMINEE'S NAME IN THE LIST BELOW:

     William W. R. Elder, Todd S. Myhre, Steve Fisher and Mario M. Rosati

     2.   Proposal to approve the amendment of the Company's 1991 Incentive
Stock Option Plan to increase the number of shares of Common Stock reserved for
issuance thereunder by 500,000 to 2,053,006 shares:

     / / FOR       / / AGAINST     / / ABSTAIN

     3.   Proposal to approve the amendment of the Company's 1989 Employee
Stock Purchase Plan to increase the number of shares of Common Stock reserved
for issuance thereunder by 250,000 to 1,300,000 shares:

     / / FOR       / / AGAINST     / / ABSTAIN

     4.   Proposal to ratify the appointment of Coopers & Lybrand LLP as the
independent public accountants of the Company for the 1995 fiscal year:

     / / FOR       / / AGAINST     / / ABSTAIN

     5.  In their discretion upon such other matter or matters which may
properly come before the meeting and any continuation(s) or adjournment(s)
thereof.

     THIS PROXY WILL BE VOTED AS DIRECTED OR, IF NO CONTRARY DIRECTION IS
INDICATED, WILL BE VOTED FOR THE ELECTION OF DIRECTORS, FOR THE AMENDMENT OF THE
1991 INCENTIVE STOCK OPTION PLAN, FOR THE AMENDMENT OF THE 1989 EMPLOYEE STOCK
PURCHASE PLAN, FOR THE RATIFICATION OF THE APPOINTMENT OF COOPERS & LYBRAND LLP
AS INDEPENDENT PUBLIC ACCOUNTANTS AND AS SAID PROXIES DEEM ADVISABLE ON SUCH
OTHER MATTERS AS MAY COME BEFORE THE MEETING.

     Such attorney or substitute shall have and may exercise all of the powers
of said attorney-in-fact hereunder.

Signature(s)______________________________________________ Date________________
(This Proxy should be dated, signed by the shareholder(s) exactly as his or
her name appears hereon, and returned promptly in the enclosed envelope.
Persons signing in a fiduciary capacity should so indicate.  If shares are held
by joint tenants or as community property, both should sign.)



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission